• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非瓣膜性心房颤动患者的体重指数增加与左心房血栓风险——来自经食管超声心动图左心房血栓(LATTEE)登记研究的数据。

Increased Body Mass Index and Risk of Left Atrial Thrombus in Nonvalvular Atrial Fibrillation Patients-Data from the Left Atrial Thrombus on Transesophageal Echocardiography (LATTEE) Registry.

机构信息

Department of Cardiology and Internal Diseases, Military Institute of Medicine, 01-755 Warsaw, Poland.

"Club 30", Polish Cardiac Society, 40-001 Katowice, Poland.

出版信息

Nutrients. 2022 Sep 4;14(17):3652. doi: 10.3390/nu14173652.

DOI:10.3390/nu14173652
PMID:
36079909
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9460640/
Abstract

An increased body mass index (BMI) is associated with a higher incidence of atrial fibrillation (AF) and a higher risk of thromboembolic complications in AF patients. The aim of this study was to investigate the effect of BMI on the risk of left atrial thrombi (LATs) in patients with nonvalvular AF/atrial flutter (AFl) (NV AF/AFl). Patients diagnosed with NVAF/AFl (between November 2018 and May 2020) were selected from the multicenter, prospective, observational Left Atrial Thrombus on Transesophageal Echocardiography (LATTEE) registry that included AF/AFl patients referred for cardioversion or ablation followed by transesophageal echocardiography. A total of 2816 AF/AFl patients (63.6% males; mean age 65.8 years; mean BMI 29.8 kg/m2) were included in the study. Two hundred and twenty-two of them (7.9%) had LATs. Compared with normal-weight patients, those with BMIs ≥ 25 kg/m2 more frequently presented clinical factors potentially provoking LATs, such as non-paroxysmal AF/AFl (p = 0.04), hypertension (p < 0.001), and diabetes (p < 0.001); had higher CHA2DS2 scores (p < 0.001); and had larger LA dimensions (LA diameter and LA area) (p < 0.001 for both parameters). On the other hand, they showed some features negatively related to thromboembolic risk; for example, they were younger (p < 0.001) and were more often male (p = 0.002). In addition, patients with abnormal BMIs were more likely to be smokers (p = 0.006) and to be treated with oral anticoagulants (p = 0.005). Despite these differences in the prevalence of thromboembolic risk factors, the incidence of LATs was not increased in patients with abnormal body weight (overweight and obese compared to normal-weight patients) in this large real-life cohort of AF/AFl patients. This is probably due to the balanced composition regarding the prevalence of positive and negative thromboembolic risk factors.

摘要

体重指数(BMI)升高与心房颤动(AF)发生率增加以及 AF 患者血栓栓塞并发症风险升高相关。本研究旨在探讨 BMI 对非瓣膜性 AF/心房扑动(AFl)(NV AF/AFl)患者左心房血栓(LAT)风险的影响。该研究从多中心、前瞻性、观察性左心房血栓经食管超声心动图(LATTEE)登记处中选取了诊断为 NVAF/AFl(2018 年 11 月至 2020 年 5 月)的患者,这些患者被转诊进行电复律或消融,随后进行经食管超声心动图检查。共纳入 2816 例 AF/AFl 患者(63.6%为男性;平均年龄 65.8 岁;平均 BMI 29.8kg/m2)。其中 222 例(7.9%)存在 LAT。与正常体重患者相比,BMI≥25kg/m2 的患者更常出现可能导致 LAT 的临床因素,如非阵发性 AF/AFl(p=0.04)、高血压(p<0.001)和糖尿病(p<0.001);CHA2DS2 评分更高(p<0.001);左心房尺寸(左房直径和左房面积)更大(p<0.001)。另一方面,他们存在一些与血栓栓塞风险负相关的特征;例如,他们更年轻(p<0.001),且更常为男性(p=0.002)。此外,BMI 异常的患者更可能为吸烟者(p=0.006),并接受口服抗凝剂治疗(p=0.005)。尽管 AF/AFl 患者的血栓栓塞危险因素流行率存在这些差异,但在该大型真实世界 AF/AFl 患者队列中,异常体重(超重和肥胖与正常体重患者相比)患者的 LAT 发生率并未增加。这可能是由于阳性和阴性血栓栓塞危险因素的流行率均衡所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf5/9460640/d4b06e9827b4/nutrients-14-03652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf5/9460640/d4b06e9827b4/nutrients-14-03652-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7cf5/9460640/d4b06e9827b4/nutrients-14-03652-g001.jpg

相似文献

1
Increased Body Mass Index and Risk of Left Atrial Thrombus in Nonvalvular Atrial Fibrillation Patients-Data from the Left Atrial Thrombus on Transesophageal Echocardiography (LATTEE) Registry.非瓣膜性心房颤动患者的体重指数增加与左心房血栓风险——来自经食管超声心动图左心房血栓(LATTEE)登记研究的数据。
Nutrients. 2022 Sep 4;14(17):3652. doi: 10.3390/nu14173652.
2
Risk factors for left atrial thrombus in younger patients (aged < 65 years) with atrial fibrillation or atrial flutter: Data from the multicenter left atrial thrombus on transesophageal echocardiography (LATTEE) registry.年龄小于65岁的房颤或房扑年轻患者左心房血栓形成的危险因素:来自多中心经食管超声心动图左心房血栓(LATTEE)注册研究的数据。
Front Cardiovasc Med. 2022 Oct 12;9:973043. doi: 10.3389/fcvm.2022.973043. eCollection 2022.
3
Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.抗凝治疗的心房颤动患者左心房血栓的发生率。
J Am Coll Cardiol. 2021 Jun 15;77(23):2875-2886. doi: 10.1016/j.jacc.2021.04.036.
4
Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF).心房颤动或心房扑动患者左心房血栓溶解情况:利伐沙班前瞻性研究(X-TRA)及提供基线数据的回顾性观察登记研究(CLOT-AF)结果
Am Heart J. 2016 Aug;178:126-34. doi: 10.1016/j.ahj.2016.05.007. Epub 2016 May 17.
5
Can transesophageal echocardiography be safely omitted in patients scheduled for elective ablation of atrial arrhythmias? Data based on the LATTEE registry.择期行心房心律失常消融术的患者能否安全地省略经食管超声心动图?基于 LATTEE 注册研究的数据。
Kardiol Pol. 2024;82(5):492-499. doi: 10.33963/v.phj.100081. Epub 2024 Apr 12.
6
Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF).一项探索每日一次口服利伐沙班(X-TRA)对非瓣膜性心房颤动或心房扑动患者左心房/左心耳血栓结局影响的研究的原理与设计,以及一项提供基线数据的回顾性观察性注册研究(CLOT-AF)。
Am Heart J. 2015 Apr;169(4):464-71.e2. doi: 10.1016/j.ahj.2014.12.020. Epub 2015 Jan 6.
7
Prevalence of auricular thrombosis before atrial flutter cardioversion: a 17-year transoesophageal echocardiographic study.心房扑动复律前耳状血栓形成的患病率:一项为期17年的经食管超声心动图研究。
Europace. 2016 Mar;18(3):450-6. doi: 10.1093/europace/euv128. Epub 2015 May 27.
8
[Thromboembolic risk factors in atrial flutter. Transesophageal echocardiographic study].[心房扑动中的血栓栓塞危险因素。经食管超声心动图研究]
Rev Med Chil. 2000 Dec;128(12):1327-34.
9
Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance.心房扑动患者左心房腔及心耳血栓的患病率及其临床意义。
J Am Coll Cardiol. 2001 Sep;38(3):778-84. doi: 10.1016/s0735-1097(01)01463-2.
10
Outcome of Anticoagulation Therapy of Left Atrial Thrombus or Sludge in Patients With Nonvalvular Atrial Fibrillation or Flutter.非瓣膜性心房颤动或房扑患者左心房血栓或血泥的抗凝治疗结果。
Am J Med Sci. 2019 Oct;358(4):273-278. doi: 10.1016/j.amjms.2019.07.013. Epub 2019 Aug 1.

引用本文的文献

1
Association of Body Mass Index with Echocardiographic Parameters and Incidence of Left Atrial Thrombus or Spontaneous Echo Contrast in Patients with Nonvalvular Atrial Fibrillation: A Cross-Sectional Study.非瓣膜性心房颤动患者体重指数与超声心动图参数及左心房血栓或自发回声增强发生率的相关性:一项横断面研究
Rev Cardiovasc Med. 2024 Dec 31;26(1):26014. doi: 10.31083/RCM26014. eCollection 2025 Jan.

本文引用的文献

1
Risk of left atrial appendage thrombus in older patients with atrial fibrillation.老年房颤患者左心耳血栓形成的风险
Arch Med Sci. 2021 Mar 3;19(6):1721-1730. doi: 10.5114/aoms/126028. eCollection 2023.
2
Left Atrial Thrombus in Atrial Fibrillation/Flutter Patients in Relation to Anticoagulation Strategy: LATTEE Registry.心房颤动/扑动患者左心房血栓与抗凝策略的关系:LATTEE注册研究
J Clin Med. 2022 May 11;11(10):2705. doi: 10.3390/jcm11102705.
3
Prevalence of Left Atrial Thrombus in Anticoagulated Patients With Atrial Fibrillation.
抗凝治疗的心房颤动患者左心房血栓的发生率。
J Am Coll Cardiol. 2021 Jun 15;77(23):2875-2886. doi: 10.1016/j.jacc.2021.04.036.
4
Atrial thrombus detection on transoesophageal echocardiography in patients with atrial fibrillation undergoing cardioversion or catheter ablation: A pooled analysis of rates and predictors.经食管超声心动图在心房颤动患者行转复或导管消融术中检测心房血栓:发生率和预测因素的汇总分析。
J Cardiovasc Electrophysiol. 2021 Aug;32(8):2179-2188. doi: 10.1111/jce.15082. Epub 2021 May 18.
5
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.2021年欧洲心律协会心房颤动患者使用非维生素K拮抗剂口服抗凝药实用指南。
Europace. 2021 Oct 9;23(10):1612-1676. doi: 10.1093/europace/euab065.
6
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
7
Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial Fibrillation.左心室射血分数与房颤患者左心耳血栓形成的风险相关。
Cardiovasc Ther. 2020 Apr 24;2020:3501749. doi: 10.1155/2020/3501749. eCollection 2020.
8
Metabolic Syndrome and Risk of Ischemic Stroke in Atrial Fibrillation: ARIC Study.代谢综合征与心房颤动缺血性卒中风险:ARIC 研究。
Stroke. 2019 Nov;50(11):3045-3050. doi: 10.1161/STROKEAHA.119.025376. Epub 2019 Oct 18.
9
The rationale and design of the LATTEE registry - the first multicenter project on the Scientific Platform of the "Club 30" of the Polish Cardiac Society.LATTEE注册研究的基本原理与设计——波兰心脏病学会“30俱乐部”科学平台上的首个多中心项目。
Kardiol Pol. 2019 Nov 22;77(11):1078-1080. doi: 10.33963/KP.15011. Epub 2019 Oct 1.
10
Impact of Body Mass Index on the Outcomes of Catheter Ablation of Atrial Fibrillation: A European Observational Multicenter Study.体重指数对房颤导管消融结局的影响:一项欧洲观察性多中心研究。
J Am Heart Assoc. 2019 Oct 15;8(20):e012253. doi: 10.1161/JAHA.119.012253. Epub 2019 Oct 4.